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INTRODUCTION
Anal lesions affect up to 34% of patients with Acquired
Immunodeficiency Syndrome (AIDS),1 and are more fre-
quent in males who have sex with males (MSM).2 The most
common anal infection in human immunodeficiency virus
(HIV)-positive patients is caused by human papillomavirus
(HPV).2,3 It is suggested that the appearance of this illness
is related to the conversion of HIV into AIDS.2,4,5 Even with
the introduction of highly-active antiretroviral therapy
(HAART), the prevalence of HPV infection in HIV-posi-
tive patients has not decreased, nor has anal cancer inci-
dence.6 It is well-known that HPV infection in HIV-posi-
tive patients is a risk factor for the development of squa-
mous cell cancer of the anus. Routine screening is strongly
recommended in this population in order to identify pre-
malignant lesions. 6
HPV infection frequently manifests as verrucous lesions
(warts) that cause pruritus, discomfort, and, more rarely,
pain or bleeding.2,3 However, some other infectious agents
such as varicella-zoster virus (VZV), cytomegalovirus
(CMV), molluscum contagiosum (MC), and particularly
herpes simplex virus (HSV), can also cause verrucous skin
lesions in HIV-positive patients.7
Herpes simplex virus is found in 29% of MSM with
symptomatic anorectal disease,3 although the majority of
confirmed herpes simplex cases are reported in asympto-
matic individuals.3,8 The most frequently encountered find-
ings are ulcerated aphthous lesions, vesicles and inguinal
lymphadenopathy.3,9 Additional signs and symptoms include
pain, pruritus, lymphadenopathy, superficial ulcers, vesicu-
lar erosion,3,9,10 urinary retention11,12 and constipation.12,13
A very small number of cases of verrucous herpes of
the perineum have been reported in the English medical
literature and treatment options varied, including the use
of acyclovir,4,14 valacyclovir15 and surgical resection.16 We
report a case of a perianal verrucous lesions that was ini-
tially suspected to be anal neoplasia, but was revealed to
be a herpes infection. The patient required surgical resec-
tion after antiviral therapy failure. This article reviews the
literature in order to describe the main characteristics of
patients with verrucous perineal herpes infection and the
outcomes of different treatment modalities. 
CASE REPORT
A 39-year-old male was referred to our service who
complained of having had verrucous and painful perianal
nodules for 3 months. He had a 10-year history of HIV in-
fection and had been using HAART for the last two years.
His CD4 T cell count was 400/¼l and his HIV viral load
was 60.000 copies per ml.
The proctologic exam revealed painful 2-3 cm verru-
cous perianal nodules (Figure 1). Endoscopy of the rectum
and sigmoid was normal. Bilateral inguinal lymphadenopa-
thy was detected during the physical exam. An anal pap
smear revealed high-grade anal dysplasia, while a conven-
tional pathologic exam of perianal lesions revealed no dys-
plasia but demonstrated cytoarchitectural alterations com-
patible with HSV infection. Immunohistochemical tests
Figure 1 - Initial proctologic exam.
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b114® for HSV type 1 and b116® for HSV type 2 from
Dako Denmark A/S (Glostrup - Denmark) revealed the pres-
ence of HSV type 2. Fungal and acid-alcohol resistant ba-
cilli screening were negative.
The patient was administered oral acyclovir for four
weeks (2.4 g/d). Because there was minimal or no regres-
sion of the lesions and persistence of the pain, we chose
to resect all lesions. After surgery, the patient was admin-
istered prophylactic acyclovir. Disease recurrence was not
detected after a 9-month follow-up (Figure 2).
DISCUSSION
Our review of the English language medical literature
published within the last 15 years identified eight cases of
Table1 - Patients with anal hypertrophic herpes. 
Author and Year Case HSV Age Gender CD4+ T Treatment Recurrence Follow-up Prophylaxy
Number type lymphocyte (mo) (mo)
count
(cells/µL)
Tong et al. (1996) 1 (HSV2) 32 M 13 Acyclovir No NA NR
(6 wks)
Saramatunga et al. (2001) 2 (HSV2) 46 M 470 LE alone No 11 Valacyclovir
(oral)
Gubinelli et al. (2003) 3 (HSV1) 46 M 500 Acyclovir No 4 Valacyclovir
(oral, failure) + (oral)
valacyclovir
(oral, 2 mo)
Nadal et al. (2005) 4 (HSV1) 41 M 73 LE alone 12 NA Not used
Nadal et al. (2005) 5 (HSV2) 46 M 370 LE alone resolution 24 Not used
Nadal et al. (2005) 6 (HSV2) 49 M 186 Acyclovir 10 NA Not used
(oral, topical
& IV) + LE
Nadal et al. (2005) 7 (HSV2) 42 M 251 Acyclovir 3 NA Not used
(oral, topical
& IV) + LE
Nadal et al. (2005) 8 (HSV2) 54 F 116 Acyclovir resolution 12 Not used
(oral, topical
& IV) + LE
Present case 9 (HSV 2) 39 M 400 Acyclovir resolution 9 Acyclovir
(oral) + LE (oral)
HSV = herpes simplex virus; NA = not applicable; NR = not reported; LE = local excision; IV = intravenous; M = male; F = female 
Figure 2 - Proctologic exam after surgery.
verrucous perineal herpes infection. The patient character-
istics are summarized and compared to the findings from
our case in Table 1. Data from the literature demonstrate
that this atypical presentation of herpes infection has a pre-
dilection for middle-aged males infected with HIV.4,15,16,17
The features of the present case were found to be similar
to those reviewed in the literature.
The patient characteristics reported in the literature sug-
gest risk factors for this uncommon presentation. An
immunocompromised status, which is related to HIV in-
fection, was reported in all cases of perianal verrucous her-
petic lesions, which suggests that it may be a significant
factor. Additionally, all patients had CD4 T cell counts
lower than 500 cells/µL, despite the use of HAART. A his-
tory of receptive anal intercourse may also play an impor-
tant role in this affliction. Although this issue was not al-
ways addressed in previous reports, two of the patients were
MSM.4,15
HSV, as well as VZV, CMV, MC and HPV infections,
can manifest as hyperkeratosis5 and verrucous4 lesions in
HIV-positive patients. The cause for this manifestation of
herpes simplex infection is unknown,4,14 although many hy-
potheses have been postulated. According to Smith et al.,5
there is an increased number of dendritic cells that are posi-
tive for XIIIa factor, which might be related to the
pathogenesis of HIV18,19 as these cells can work as an
enervator of the virus in the skin.20,21 These dendritic cells,
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can produce TNF-alpha in certain conditions, which might
increase the growth index of keratinocytes22,23 and generate
acanthosys and hyperkeratosis. In uninfected people, vari-
ous stimuli of keratinocytes are inhibited by IFN-gamma,
which is produced by cytotoxic T cells and T helper cells.
This mechanism is diminished in HIV-infected patients.23
Interestingly, the majority (7/9) of the lesions in the re-
ported cases were caused by HSV2 (cases 1, 2, and 5-9).
However, due to the small number of cases, an association
between HSV type and verrucous lesions cannot be as-
sumed.
Regarding the treatment modalities and outcomes, it is
difficult to compare the results from previous reports to our
case. As seen in Table 1, there was significant treatment
diversity among these nine cases and relatively short fol-
low-up. However, it must be emphasized that although two
cases were successfully treated with antiviral therapy alone
(cases 1 and 3), the majority of cases (7/9) received local
excision as part of their treatment. Local excision alone was
performed in three cases (cases 1, 4 and 5) and in combi-
nation with upfront antiviral therapy in four cases (cases
6-9). Among these seven surgically treated patients, three
of them presented with disease recurrence (cases 4, 6 and
7) despite the administration of oral and topical acyclovir
to two of them (cases 6 and 7). The use of prophylactic
acyclovir after surgical treatment effectively prevented dis-
ease recurrence in our patient during the nine-month fol-
low-up period.
According to the literature, patients with HSV infec-
tions resistant to acyclovir, which usually occurs after ir-
regular use of the drug,7 could be treated with foscarnet24
and beta-interferon.10 Because valacyclovir is more
bioavailable than acyclovir, it was more effective in the
resolution of cutaneous HSV infections.25,26
Despite the relatively short follow-up period in these
reports, they suggest that prophylactic use of oral acyclovir
or valacyclovir may prevent recurrence. In addition, there
is evidence which indicates that the survival of patients with
AIDS and previous exposure to herpes virus infections may
increase with chronic use of suppressive therapy with
acyclovir.27 Moreover, the evidence seems to support pro-
phylactic use of these drugs. 
CONCLUSION
Atypical presentation of herpes simplex infection should
be considered as a differential diagnosis of perianal neo-
plasia in HIV-positive patients, because the nature of this
presentation may be related to an immunocompromised sta-
tus. Surgical resection followed by acyclovir prophylactic
treatment appears to be an effective therapy.
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